3-substitued indoles: one-pot synthesis and evaluation of anticancer and Src kinase inhibitory activities. 2011

V Kameshwara Rao, and Bhupender S Chhikara, and Amir Nasrolahi Shirazi, and Rakesh Tiwari, and Keykavous Parang, and Anil Kumar
Department of Chemistry, Birla Institute of Technology and Science, Pilani, Rajasthan, India.

An efficient and economical method was developed for the synthesis of 3-substituted indoles by one-pot three-component coupling reaction of a substituted or unsubstituted benzaldehyde, N-methylaniline, and indole or N-methylindole using Yb(OTf)(3)-SiO(2) as a catalyst. All the synthesized compounds were evaluated for inhibition of cell proliferation of human colon carcinoma (HT-29), human ovarian adenocarcinoma (SK-OV-3), and c-Src kinase activity. The 4-methylphenyl (4o and 4p) and 4-methoxyphenyl (4q) indole derivatives inhibited the cell proliferation of SK-OV-3 and HT-29 cells by 70-77% at a concentration of 50 μM. The unsubstituted phenyl (4d) and 3-nitrophenyl (4l) derivatives showed the inhibition of c-Src kinase with IC(50) values of 50.6 and 58.3 μM, respectively.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D002384 Catalysis The facilitation of a chemical reaction by material (catalyst) that is not consumed by the reaction. Catalyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000814 Aniline Compounds Compounds that include the aminobenzene structure. Phenylamine,Phenylamines,Anilines,Compounds, Aniline
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001547 Benzaldehydes Compounds that consist of a benzene ring with a formyl group. They occur naturally in the seeds of many fruits and are used as FLAVORING AGENTS and fragrances, as well as precursors in pharmaceutical and plastics manufacturing.
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D012822 Silicon Dioxide Transparent, tasteless crystals found in nature as agate, amethyst, chalcedony, cristobalite, flint, sand, QUARTZ, and tridymite. The compound is insoluble in water or acids except hydrofluoric acid. Silica,Aerosil,Aerosil 380,Cristobalite,Quso G-32,Quso G32,Tridymite,380, Aerosil,Dioxide, Silicon,G32, Quso,Quso G 32
D015018 Ytterbium An element of the rare earth family of metals. It has the atomic symbol Yb, atomic number 70, and atomic weight 173. Ytterbium has been used in lasers and as a portable x-ray source.

Related Publications

V Kameshwara Rao, and Bhupender S Chhikara, and Amir Nasrolahi Shirazi, and Rakesh Tiwari, and Keykavous Parang, and Anil Kumar
December 2012, Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences,
V Kameshwara Rao, and Bhupender S Chhikara, and Amir Nasrolahi Shirazi, and Rakesh Tiwari, and Keykavous Parang, and Anil Kumar
March 2011, Bioorganic & medicinal chemistry letters,
V Kameshwara Rao, and Bhupender S Chhikara, and Amir Nasrolahi Shirazi, and Rakesh Tiwari, and Keykavous Parang, and Anil Kumar
September 2011, Medicinal chemistry (Shariqah (United Arab Emirates)),
V Kameshwara Rao, and Bhupender S Chhikara, and Amir Nasrolahi Shirazi, and Rakesh Tiwari, and Keykavous Parang, and Anil Kumar
October 2011, European journal of medicinal chemistry,
V Kameshwara Rao, and Bhupender S Chhikara, and Amir Nasrolahi Shirazi, and Rakesh Tiwari, and Keykavous Parang, and Anil Kumar
September 2010, Biochimie,
V Kameshwara Rao, and Bhupender S Chhikara, and Amir Nasrolahi Shirazi, and Rakesh Tiwari, and Keykavous Parang, and Anil Kumar
July 2016, Bioorganic & medicinal chemistry letters,
V Kameshwara Rao, and Bhupender S Chhikara, and Amir Nasrolahi Shirazi, and Rakesh Tiwari, and Keykavous Parang, and Anil Kumar
January 2011, Bioorganic & medicinal chemistry letters,
V Kameshwara Rao, and Bhupender S Chhikara, and Amir Nasrolahi Shirazi, and Rakesh Tiwari, and Keykavous Parang, and Anil Kumar
November 2022, ACS omega,
V Kameshwara Rao, and Bhupender S Chhikara, and Amir Nasrolahi Shirazi, and Rakesh Tiwari, and Keykavous Parang, and Anil Kumar
April 2014, Bioorganic chemistry,
V Kameshwara Rao, and Bhupender S Chhikara, and Amir Nasrolahi Shirazi, and Rakesh Tiwari, and Keykavous Parang, and Anil Kumar
September 2004, European journal of medicinal chemistry,
Copied contents to your clipboard!